JEZABEL NOVO-FRIAS: Open Payments
NPI 1336590355 · NEW PROVIDENCE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$90 in 5 payments from 3 companies in 2025. Trend: 2023 $104 · 2024 $521 · 2025 $90
Food & beverage: $90
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $50 |
| Optinose US, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $15 |
Products named: NUCALA, Xhance, CDS - MCT/CEM Monitoring.
Industry payments across NJ — which companies pay providers there.
